By Randy Goodman, PhD In the evolving landscape of innovative therapeutics, radiopharmaceuticals stand out as a powerful modality to diagnose, target, and treat disease at the molecular level. This interest and excitement is re...
Radiopharmaceuticals
Navigating the CMC Journey in Radiopharmaceuticals
Insights from the “Tinker to Treasure” Webinar The development of radiopharmaceuticals offers tremendous potential for both the diagnosis and treatment of disease. However, turning early-stage research into a market-ready produ...
FDA Nonclinical Requirements for Radiopharmaceutical Drugs: Diagnostic vs. Therapeutic Pathways
By Dr. Bill F. Hodnick, DABT If you are developing a radiopharmaceutical drug and preparing for an Investigational New Drug (IND) filing, understanding nonclinical requirements set by the Food and Drug Administration (FDA) is e...
gET sOCIAL